{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:11:39Z","timestamp":1777637499402,"version":"3.51.4"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbrc.2026.153532","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:38:50Z","timestamp":1772177930000},"page":"153532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Methyl divanillate enhances doxorubicin efficacy in TNBC cell lines through redox imbalance and apoptotic reprogramming"],"prefix":"10.1016","volume":"810","author":[{"given":"Adriano de Souza","family":"Pessoa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via Godoy","family":"Iano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Liessa Rovis","family":"Sanches","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuelle Pangoni de","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L\u00edgia","family":"Pagnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1469-5224","authenticated-orcid":false,"given":"Larissa Terc\u00edlia Grizzo","family":"Thomassian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talita Mendes Oliveira","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00edlia Afonso Rabelo","family":"Buzalaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valdecir Farias","family":"Ximenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3070-5960","authenticated-orcid":false,"given":"Rodrigo Cardoso de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153532_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer \u2014 expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.153532_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.bbrc.2026.153532_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.153532_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbrc.2026.153532_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13045-023-01497-3","article-title":"Recent advances in targeted strategies for triple-negative breast cancer","volume":"16","author":"Zhu","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.153532_bib6","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/cancers11091334","article-title":"Triple-negative breast cancer: current understanding and future therapeutic breakthrough targeting cancer stemness","volume":"11","author":"Lee","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.153532_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153532_bib8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin\u2014an agent with multiple mechanisms of anticancer activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153532_bib9","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: the good, the bad and the ugly effect","volume":"16","author":"Carvalho","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.153532_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00280-022-04400-y","article-title":"Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells","volume":"89","author":"Nicoletto","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153532_bib11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7150\/ijbs.65258","article-title":"Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death","volume":"18","author":"Kong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.153532_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153532_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178597","article-title":"Induction of axial chirality in divanillin by interaction with bovine serum albumin","volume":"12","author":"Venturini","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153532_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109962","article-title":"The dimerization of methyl vanillate improves its effect against breast cancer cells via pro-oxidant effect","volume":"361","author":"Pessoa","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbrc.2026.153532_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.00033","article-title":"Is it time to start transitioning from 2D to 3D cell culture?","volume":"7","author":"Jensen","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbrc.2026.153532_bib16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/cancers14010190","article-title":"3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs","volume":"14","author":"Barbosa","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.153532_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212200","article-title":"3D cell culture systems: tumor application, advantages, and disadvantages","volume":"22","author":"Habanjar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153532_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12929-024-00994-y","article-title":"Scaffold-based 3D cell culture models in cancer research","volume":"31","author":"Abuwatfa","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbrc.2026.153532_bib19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1039\/C9TB02266J","article-title":"Mitochondria-targeted tetrahedral DNA nanostructures for doxorubicin delivery and enhancement of apoptosis","volume":"8","author":"Yan","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bbrc.2026.153532_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/carcin\/bgad086","article-title":"Actinomycin D synergizes with doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis","volume":"45","author":"Yang","year":"2024","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2026.153532_bib21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3892\/ijo.2016.3558","article-title":"Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines","volume":"49","author":"Pilco-Ferreto","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2026.153532_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114259","article-title":"Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters","volume":"182","author":"Sudhakaran","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153532_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-022-06514-6","article-title":"Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT","volume":"193","author":"Zhu","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbrc.2026.153532_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2019.02.003","article-title":"Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway","volume":"142","author":"Peng","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.153532_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/carcin\/bgz172","article-title":"TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer","volume":"41","author":"Peeney","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2026.153532_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12943-016-0515-5","article-title":"Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer","volume":"15","author":"Cheng","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.153532_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10555-019-09812-6","article-title":"Functional disparities within the TIMP family in cancer: hints from molecular divergence","volume":"38","author":"Eckfeld","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbrc.2026.153532_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.606149","article-title":"Transgelin-2: a double-edged sword in immunity and cancer metastasis","volume":"9","author":"Kim","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2026.153532_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.573859","article-title":"Transgelins: cytoskeletal associated proteins implicated in the metastasis of colorectal cancer","volume":"8","author":"Liu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2026.153532_bib30","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/1535-7163.MCT-19-0261","article-title":"Transgelin 2 promotes paclitaxel resistance, migration, and invasion of breast cancer by directly interacting with PTEN and activating PI3K\/Akt\/GSK-3\u03b2 pathway","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.bbrc.2026.153532_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1236158","article-title":"Editorial: molecular and multi-omic approaches in understanding cancer biology and anticancer therapies: current perspectives and new challenges","volume":"14","author":"Abdel-Wahab","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153532_bib32","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1007\/s12094-024-03819-4","article-title":"Pan-cancer and multiomics: advanced strategies for diagnosis, prognosis, and therapy in the complex genetic and molecular universe of cancer","volume":"27","author":"Campanharo","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bbrc.2026.153532_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/proteomes11040034","article-title":"Multi-omics integration for the design of novel therapies and the identification of novel biomarkers","volume":"11","author":"Ivanisevic","year":"2023","journal-title":"Proteomes"},{"key":"10.1016\/j.bbrc.2026.153532_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040683","article-title":"Magnetically bioprinted human myometrial 3D cell rings as a model for uterine contractility","volume":"18","author":"Souza","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153532_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep30640","article-title":"A high-throughput in vitro ring assay for vasoactivity using magnetic 3D bioprinting","volume":"6","author":"Tseng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153532_bib36","first-page":"1","article-title":"Luminescent viability assays in magnetically bioprinted 3D cultures","author":"Tseng","year":"2015","journal-title":"Promega Corp."},{"key":"10.1016\/j.bbrc.2026.153532_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vascn.2018.03.007","article-title":"Real time monitoring and quantification of reactive oxygen species in breast cancer cell line MCF-7 by 2\u2032,7\u2032\u2013dichlorofluorescin diacetate (DCFDA) assay","volume":"94","author":"Figueroa","year":"2018","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bbrc.2026.153532_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2024.106697","article-title":"Antitumor effect of bromo-naphthoquinone associated with tannic acid in triple negative breast cancer cells","volume":"177","author":"de Carvalho","year":"2024","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153532_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101705","article-title":"Anti-tumour potential and selectivity of caffeic acid phenethyl ester in osteosarcoma cells","volume":"74","author":"Pagnan","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.bbrc.2026.153532_bib40","first-page":"120","article-title":"ZIMOGRAFIA: princ\u00edpios, tipos E FATORES de interfer\u00eancia","volume":"vol. 3","author":"Baptista","year":"2023"},{"key":"10.1016\/j.bbrc.2026.153532_bib41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jep.2019.03.052","article-title":"An extract from Myracrodruon urundeuva inhibits matrix mineralization in human osteoblasts","volume":"237","author":"Matos","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2026.153532_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jphotobiol.2016.08.006","article-title":"Low intensity lasers differently induce primary human osteoblast proliferation and differentiation","volume":"163","author":"Oliveira","year":"2016","journal-title":"J. Photochem. Photobiol., B"},{"key":"10.1016\/j.bbrc.2026.153532_bib43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the chou-talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153532_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.bbrc.2026.153532_bib45","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","author":"Bateman","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.153532_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01531","article-title":"Doxorubicin induces endotheliotoxicity and mitochondrial dysfunction via ROS\/eNOS\/NO pathway","volume":"10","author":"He","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153532_bib47","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/medicina61050798","article-title":"Genistein improves the cytotoxic, apoptotic, and oxidative-stress-inducing properties of doxorubicin in SK-MEL-28 cancer cells","volume":"61","author":"Roman","year":"2025","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.bbrc.2026.153532_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107130","article-title":"The NADPH oxidase 2 subunit p47phox binds to the WAVE regulatory complex and p22phox in a mutually exclusive manner","volume":"300","author":"Kuihon","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153532_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.54457\/DR.202402015","article-title":"Multifaced anticancer potential of doxorubicin: spotlight on breast cancer","volume":"5","author":"Swain","year":"2025","journal-title":"Dis. Res."},{"key":"10.1016\/j.bbrc.2026.153532_bib50","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3390\/antiox10101506","article-title":"Baicalin enhances chemosensitivity to doxorubicin in breast cancer cells via upregulation of oxidative stress-mediated mitochondria-dependent apoptosis","volume":"10","author":"Lin","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2026.153532_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70130","article-title":"Arginase activity inhibition with thymoquinone induces a hybrid type of cell\u2010death in MDA\u2010MB\u2010231 cell line","volume":"39","author":"Bday","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bbrc.2026.153532_bib52","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.3390\/nu15092137","article-title":"Lysophosphatidylcholine-DHA specifically induces cytotoxic effects of the MDA-MB-231 human breast cancer cell line in vitro\u2014comparative effects with other lipids containing DHA","volume":"15","author":"Mohamad Ali","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2026.153532_bib53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3892\/or.2023.8637","article-title":"Differential response of MDA-MB-231 breast cancer and MCF10A normal breast cells to cytoskeletal disruption","volume":"50","author":"Kwon","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2026.153532_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101136","article-title":"Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutaminase and glutamate export","volume":"61","author":"Choi","year":"2025","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbrc.2026.153532_bib55","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/antiox9040320","article-title":"Triple combination of ascorbate, menadione and the inhibition of Peroxiredoxin-1 produces synergistic cytotoxic effects in triple-negative breast cancer cells","volume":"9","author":"Bajor","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2026.153532_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/9051542","article-title":"ROS-mediated cancer cell killing through dietary phytochemicals","volume":"2019","author":"NavaneethaKrishnan","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2026.153532_bib57","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cells13110906","article-title":"Inhibition of PDIs downregulates core LINC complex proteins, promoting the invasiveness of MDA-MB-231 breast cancer cells in confined spaces in vitro","volume":"13","author":"Young","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153532_bib58","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12935-023-03124-0","article-title":"Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics","volume":"23","author":"Carneiro","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2026.153532_bib59","author":"Varela-Rouco"},{"key":"10.1016\/j.bbrc.2026.153532_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311149","article-title":"MCL1 inhibition overcomes the aggressiveness features of triple-negative breast cancer MDA-MB-231 cells","volume":"24","author":"Pratelli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153532_bib61","doi-asserted-by":"crossref","first-page":"9735","DOI":"10.3390\/ijms26199735","article-title":"Genes associated with apoptosis in an experimental breast cancer model","volume":"26","author":"Calaf","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153532_bib62","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3390\/ijms26157227","article-title":"Prognostic potential of apoptosis-related biomarker expression in triple-negative breast cancers","volume":"26","author":"T\u00f6r\u00f6k","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153532_bib63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1476-4598-13-228","article-title":"Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization","volume":"13","author":"Sabatier","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.153532_bib64","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","article-title":"Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer","volume":"12","author":"Prat","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153532_bib65","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3390\/cancers15102689","article-title":"Comparison of clinical subtypes of breast cancer within the claudin-low molecular cluster reveals distinct phenotypes","volume":"15","author":"Voutsadakis","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.153532_bib66","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13058-022-01501-7","article-title":"Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS\/MAPK pathway activation","volume":"24","author":"Tang","year":"2022","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153532_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/ijbs.88285","article-title":"MRCK as a potential target for claudin-low subtype of breast cancer","volume":"20","author":"Yamaguchi","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.153532_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108502","article-title":"IL-17A promotes the migration and invasiveness of cervical cancer cells by coordinately activating MMPs expression via the p38\/NF-\u03baB signal pathway","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153532_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41420-019-0167-5","article-title":"miR-4521-FAM129A axial regulation on ccRCC progression through TIMP-1\/MMP2\/MMP9 and MDM2\/p53\/Bcl2\/Bax pathways","volume":"5","author":"Feng","year":"2019","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbrc.2026.153532_bib70","doi-asserted-by":"crossref","first-page":"118","DOI":"10.18632\/oncotarget.28691","article-title":"Effect of TIMPs and their minimally engineered variants in blocking invasion and migration of brain cancer cells","volume":"16","author":"Taheri","year":"2025","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2026.153532_bib71","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.3390\/ijms25052858","article-title":"Relationship between the expression of matrix metalloproteinases and their tissue inhibitors in patients with brain tumors","volume":"25","author":"Dibdiakova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153532_bib72","doi-asserted-by":"crossref","first-page":"15966","DOI":"10.18632\/oncotarget.3862","article-title":"Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2026.153532_bib73","first-page":"530","article-title":"[the influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro]","volume":"86","author":"Zhang","year":"2006","journal-title":"Zhonghua Yixue Zazhi"},{"key":"10.1016\/j.bbrc.2026.153532_bib74","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s12672-024-01593-x","article-title":"TLN1: an oncogene associated with tumorigenesis and progression","volume":"15","author":"Li","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbrc.2026.153532_bib75","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbrc.2020.01.028","article-title":"Transgelin-2 contributes to proliferation and progression of hepatocellular carcinoma via regulating annexin A2","volume":"523","author":"Shi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153532_bib76","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.1038\/sj.onc.1208993","article-title":"Resensitization of breast cancer cells to anoikis by Tropomyosin-1: role of rho kinase-dependent cytoskeleton and adhesion","volume":"24","author":"Bharadwaj","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.153532_bib77","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1002\/jcb.26185","article-title":"Therapeutic potential of matrix metalloproteinase inhibition in breast cancer","volume":"118","author":"Radisky","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2026.153532_bib78","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.3390\/ijms26178506","article-title":"Mandragora autumnalis: phytochemical composition, antioxidant and anti-cancerous bioactivities on triple-negative breast cancer cells","volume":"26","author":"Albahri","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153532_bib79","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/PAI.0000000000001261","article-title":"TAGLN2-mediated actin cytoskeleton stabilization promotes proliferation and metastasis of ovarian carcinoma","volume":"33","author":"Qiu","year":"2025","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.bbrc.2026.153532_bib80","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgaf014","article-title":"Multifaceted role of transgelin isoforms in cancer hallmarks","volume":"46","author":"Jimenez Jimenez","year":"2025","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2026.153532_bib81","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1021\/pr900705r","article-title":"Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and Transgelin-2 in lung adenocarcinoma and its stroma","volume":"8","author":"Rho","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbrc.2026.153532_bib82","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1111\/cas.13791","article-title":"Hypoxia\u2010inducible transgelin 2 selects epithelial\u2010to\u2010mesenchymal transition and \u03b3\u2010radiation\u2010resistant subtypes by focal adhesion kinase\u2010associated insulin\u2010like growth factor 1 receptor activation in non\u2010small\u2010cell lung cancer cells","volume":"109","author":"Kim","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2026.153532_bib83","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13046-017-0619-9","article-title":"TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas","volume":"36","author":"Han","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153532_bib84","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41419-024-07000-1","article-title":"TAGLN2 induces resistance signature ISGs by activating AKT-YBX1 signal with dual pathways and mediates the IFN-related DNA damage resistance in gastric cancer","volume":"15","author":"Zhuo","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153532_bib85","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41586-024-08071-y","article-title":"Transgelin 2 guards T cell lipid metabolism and antitumour function","volume":"635","author":"Hwang","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153532_bib86","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12885-024-12082-3","article-title":"Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer","volume":"24","author":"Jo","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.153532_bib87","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/cancers16050978","article-title":"Circular STAG2 RNA modulates bladder cancer progression via miR-145-5p\/TAGLN2 and is considered as a biomarker for recurrence","volume":"16","author":"Du","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.153532_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217107","article-title":"Unveiling the role of TAGLN2 in glioblastoma: from proneural-mesenchymal transition to temozolomide resistance","volume":"598","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153532_bib89","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.7150\/jca.84454","article-title":"An integrated analysis identified TAGLN2 as an oncogene indicator related to prognosis and immunity in pan-cancer","volume":"14","author":"Pan","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbrc.2026.153532_bib90","doi-asserted-by":"crossref","first-page":"30943","DOI":"10.1021\/acsnano.3c12967","article-title":"Tumor-derived extracellular vesicles enable tumor tropism chemo-genetherapy for local immune activation in triple-negative breast cancer","volume":"18","author":"Peng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbrc.2026.153532_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117637","article-title":"Plant-derived extracellular vesicles release combined with systemic DOX exhibits synergistic effects in 3D bioprinted triple-negative breast cancer","volume":"181","author":"Cui","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.153532_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1608017","article-title":"Adrenergic signals influence proteomic responses in breast cancer cells","volume":"19","author":"Carrasco","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbrc.2026.153532_bib93","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.2147\/OTT.S249756","article-title":"Characterization of triple-negative breast cancer MDA-MB-231 cell spheroid model","volume":"13","author":"Huang","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrc.2026.153532_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113481","article-title":"Synergistic anti-tumor effects of Newcastle disease virus and doxorubicin: evidence from A murine breast cancer model","volume":"143","author":"Sabri","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2026.153532_bib95","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.3390\/molecules24122338","article-title":"Piperlongumine induces apoptosis and synergizes with doxorubicin by inhibiting the JAK2-STAT3 pathway in triple-negative breast cancer","volume":"24","author":"Chen","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153532_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100269","article-title":"Normics: proteomic normalization by variance and data-inherent correlation structure","volume":"21","author":"Dressler","year":"2022","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbrc.2026.153532_bib97","article-title":"Experimental reproducibility limits the correlation between mRNA and protein abundances in tumor proteomic profiles","volume":"2","author":"Upadhya","year":"2022","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.bbrc.2026.153532_bib98","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41467-017-01422-6","article-title":"Systematic proteome and proteostasis profiling in human trisomy 21 fibroblast cells","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26002962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26002962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:08:19Z","timestamp":1777442899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26002962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":98,"alternative-id":["S0006291X26002962"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153532","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methyl divanillate enhances doxorubicin efficacy in TNBC cell lines through redox imbalance and apoptotic reprogramming","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153532"}}